Metabolomics

Overview

Metabolomics is the comprehensive measurement of small-molecule metabolites (<1,500 Da) in a biological sample — the functional readout of what the genome, transcriptome, and microbiome are actually doing. While genomics tells you what organisms are present and metagenomics tells you what genes they carry, metabolomics reveals the metabolic products that directly affect the host.

In the WikiBiome context, metabolomics bridges two layers of evidence: it translates metal exposure and microbiome composition into measurable functional consequences. The integration of metallomics + metabolomics — measuring both metal speciation and metabolite profiles simultaneously — is a distinctive WikiBiome analytical approach.

Key Analytical Platforms

PlatformStrengthsCommon Use
LC-MS/MS (untargeted)Broadest coverage; discovery modeSerum, urine, fecal metabolomics
UHPLC-Q-TOF-MSHigh mass accuracy for identificationBiomarker discovery
GC-MSBest for volatile/semi-volatile metabolitesSCFA quantification
HILIC-UHPLCPolar metabolite separationAmino acids, nucleotides
NMRNon-destructive; quantitativeUrine, serum profiling
ICP-MSMetal speciationMetallomic-metabolomic integration

Metabolite Classes Relevant to WikiBiome

Short-Chain Fatty Acids ([[short-chain-fatty-acids]])

butyrate, propionate, acetate — the primary outputs of firmicutes fermentation. SCFA quantification by GC-MS is the most direct measure of beneficial microbiome metabolic activity. Depleted across inflammatory, neurodegenerative, and metabolic conditions.

Tryptophan Metabolites

The tryptophan metabolism pathway branches into serotonin, kynurenine, and indoles. Metabolomics reveals which branch dominates and whether inflammation (IDO1 induction) is diverting tryptophan from serotonin to neurotoxic kynurenine metabolites.

Bile Acids

Primary and secondary bile acid profiles reflect bile acid metabolism activity of gut bacteria. Deconjugation by BSH-producing organisms and 7-alpha-dehydroxylation are measurable metabolomic events.

Amino Acids

Branched-chain amino acids (BCAAs), aromatic amino acids, and their microbial derivatives (p-cresol, indoxyl sulfate, phenylacetylglutamine) serve as functional markers of dysbiosis.

Uremic Toxins

Indoxyl sulfate, p-cresyl sulfate, TMAO — microbially-derived metabolites that accumulate in chronic kidney disease and cardiovascular disease. Produced primarily by proteobacteria and specific firmicutes genera.

Metal-Metabolomics Integration

The most distinctive WikiBiome application: simultaneous measurement of metal speciation and metabolite profiles reveals how metal exposure reshapes microbial metabolism.

  • Iron exposure produces the most distinct metabolomic signature in C. elegans — more disruptive than zinc or manganese [1].
  • Heavy metal toxicity metabolomics reveals shared metabolic disruption patterns across Pb, Cd, Hg, As exposures (oxidative stress markers, amino acid depletion, energy metabolism disruption) [2].
  • Metallomic-metabolomic COVID profiling in mother-infant dyads revealed coordinated metal-metabolite disruption during SARS-CoV-2 infection [3].

Disease Applications

ConditionKey Metabolomic Findings
parkinsons diseaseSerum metabolomics predicts motor progression; p-cresol elevated
autism spectrum disorderUrinary tryptophan/purine metabolite disruption [4]
necrotizing enterocolitisFormate as NEC-specific metabolic marker of enteric dysbiosis [5]
type 2 diabetesMulti-omics (microbiome + metabolome) response to dietary fiber [6]
cerebral palsyAmino acid metabolomics reveals reduced tryptophan pool [7]
multiple sclerosisPro-inflammatory metabolic signatures in Graves'/Hashimoto's/MS

Cross-References

References (7)

  1. Bastian Blume, Philippe Schmitt-Kopplin, Bernhard Michalke (2026). Blume 2026 — Combined Metallomics and Metabolomics Reveal Impact of Metal Homeostasis on Biological Pathways in C. elegans. Analytical and Bioanalytical Chemistry
  2. Akash MSH, Yaqoob A, Rehman K et al. (2023). Metabolomics: a promising tool for deciphering metabolic impairment in heavy metal toxicities. Frontiers in Molecular Biosciences. doi:10.3389/fmolb.2023.1218497
  3. Arias-Borrego A, Soto Cruz FJ, Selma-Royo M et al. (2022). Metallomic and Untargeted Metabolomic Signatures of Human Milk from SARS-CoV-2 Positive Mothers. Molecular Nutrition and Food Research. doi:10.1002/mnfr.202200071
  4. Federica Gevi, Lello Zolla, Stefano Gabriele et al. (2016). Gevi 2016 — Urinary Metabolomics of Young Italian Autistic Children Supports Abnormal Tryptophan and Purine Metabolism. Molecular Autism. doi:10.1186/s13229-016-0109-5
  5. Giorgio Casaburi, Jingjing Wei, Sufyan Kazi et al. (2022). Casaburi 2022 — Formate as a metabolic driver of NEC: integrated metagenomics and targeted metabolomics. Frontiers in Pediatrics. doi:10.3389/fped.2022.893059
  6. Mohammad Tahseen Al Bataineh, Axel Kunstner, Nihar Ranjan Dash et al. (2023). Al Bataineh 2023 — Multi-Omics Analysis of Gut Microbial Dysbiosis, Metabolomics, and Dietary Intake in Type 2 Diabetes. Scientific Reports. doi:10.1038/s41598-023-45066-7
  7. Dan Wang, Juan Song, Ye Cheng et al. (2023). Wang 2023 — Plasma amino acid metabolomics identifies diagnostic signature for cerebral palsy. Frontiers in Molecular Neuroscience. doi:10.3389/fnmol.2023.1237745